Why Is Moderna (MRNA) Stock Price Up 6.98% Today, Sep 24? UAE Investment and Cancer Vaccine Data Lift MRNA to a 52-Week High
Moderna (MRNA) gained 6.98% to $194.82 on September 24, 2026, as visibility around its ESMO oncology presentations and bullish options activity supported the rally. This draft reviews the move's limits, the October clinical checkpoint, and the price levels that frame the next decision.